Data / Form D filings / Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc.: Form D filings
Aeovian Pharmaceuticals, Inc., a pharmaceuticals company in Berkeley, CA, filed 4 Form D notices with the SEC between 2017 and 2025. The latest, on December 22, 2025, reports $55 million sold of a $55 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2930 Domingo Ave., Suite 145, Berkeley, CA, 94705
- Phone
- (510) 961-1148
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1710088
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | New notice | $54,999,996 | $54,999,996 | 13 | Nov 18, 2025 | sec.gov | |
| May 13, 2024 | New notice | $50,415,077 | $50,415,077 | 5 | Dec 22, 2023 | sec.gov | |
| Oct 9, 2019 | New notice | $48,799,907 | $18,799,907 | $30,000,000 | 5 | Sep 24, 2019 | sec.gov |
| Jun 28, 2017 | New notice | $3,785,687 | $785,687 | $3,000,000 | 4 | Jun 14, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John J. Kincaid | Executive Officer | |
| Youssef J. Bennani | Director | |
| Themasap J. Khan | Director | |
| Nils J. Regge | Director | |
| Davis J. Ryman | Executive Officer | |
| William J. Greene | Director | |
| Micah J. Zajic | Executive Officer | |
| Lars J. Ekman | Director | |
| Justin J. Gover | Director | |
| Allison J. Hulme | Executive Officer, Director | |
| Richard J. Gaster | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 22, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aeovian Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.